This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
different catchment areas. A further 497 of the 1,349 that remained to be assessed were excluded because they were admitted to the hospital involuntarily, and another 61 could not be assessed for eligibility. Overall, 791 patients were assessed for eligibility. Of these, 445 patients were excluded according to clinical or social exclusion criteria, while 137 refused to participate in the study.
Two hundred and nine patients were initially randomised, 144 to the day hospital treatment group and 65 to the inpatient treatment group. After randomisation, 2 patients from the day hospital treatment group withdrew consent, while a further patient from the same group was also excluded because he had not been discharged by the end of the study period. Overall, 206 patients were included in the study, 141 in the day hospital treatment group and 65 in the inpatient care group.
Study design
The analysis was based on a multi-centre (three acute psychiatric wards) randomised controlled trial (RCT). Randomisation to the day hospital or inpatient treatment group was achieved in blocks, using sealed envelops that were opened by the researchers. The patients were followed-up at discharge and at 3 and 12 months after discharge. At discharge, 95 (46%) patients (63 in the day hospital group and 32 in the inpatient group) were lost to follow-up. This was due to unexpected discharge about which researchers were not informed, self-discharge, patients not returning from leave, and discharge because of non-attendance at the day hospital. The follow-up rate at 3 months after discharge was 71% in the day hospital group and 69% in the inpatient care group. At 12 months, the follow-up rate was 57% in the day hospital group and 55% in the inpatient hospital group. The main reason provided for losses to follow-up was to inability to contact patients. Researchers were not blinded to the treatment allocation.
Analysis of effectiveness
The analysis was conducted on an intention to treat basis. It was reported that the patient groups were comparable in terms of their baseline characteristics. In addition, it was reported that there were no statistical differences in baseline characteristics, baseline psychopathology and baseline subjective quality of life between patients who completed the study and those who were lost to follow-up.
To reflect the effectiveness of treatment, the authors used psychopathology, subjective quality of life and treatment satisfaction at discharge, 3 and 12 months post discharge, as well as readmission rates, as the primary health outcomes. Psychopathology was evaluated using the 24-item version of the Brief Psychiatric Rating Scale (BPRS) and patients' satisfaction with treatment was assessed using the Clients' Assessment of Treatment (CAT) scale. Subjective quality of life was evaluated using the Manchester Short Assessment of Quality of Life (MANSA). Patient values were used and they evaluated their satisfaction with 12 life domains on a Likert-type rating scale.
Effectiveness results
In terms of psychopathology at discharge, patients in the day hospital group (n=76) had significantly lower BPRS scores (mean score 1.63, standard error, SE=0.05) than patients in the inpatient group (n=30; mean score 1.87, SE 0.09), demonstrating greater improvement in overall psychopathology, (F=5.18, d.f. = 1, p=0.025, 95% confidence interval, CI: 0.03 to 0.45).
Length of admission did not have an impact on BPRS score at discharge. here were no statistically significant differences in BPRS scores between the two groups at 3 and 12 months after discharge.
In terms of treatment satisfaction, the mean CAT scores at discharge were significantly higher in the day hospital group (n=70; mean score 8.10, standard deviation, SD=1.99) than in the inpatient group (n=34; mean score 6.77, SD=2.26), (p=0.004).
Three months after discharge, the CAT scores remained higher for patients in the day hospital group (n=79; mean CAT score 7.31, SD=1.93) compared with those in the inpatient group (n=41; mean CAT score 6.15, SD=2.48), (p=0.005). Twelve months after discharge, the mean CAT scores between the two groups did not vary significantly.
At discharge, the mean MANSA score was 4.28 (SE=0.11) in the day hospital group and 3.87 (SE=0.18) in the The unit costs were treated deterministically. The mean treatment costs for the two groups were compared using t-tests, and the results were validated using bootstrapped (1,000 replications) CIs calculated using Stata software (release 8.0 for Windows).
Indirect Costs
The indirect costs were not included in the analysis.
Currency

UK pounds sterling ().
Sensitivity analysis
No sensitivity analysis was reported.
Estimated benefits used in the economic analysis
For BPRS scores, see the 'Effectiveness Results' section.
Cost results
The total intervention costs were estimated for 75 patients in the day hospital group and for 32 patients in the inpatient group.
During the treatment period, the mean total intervention costs were 6,523 in the day hospital group and 3,619 in the inpatient group (bootstrapped 95% CI: 375 to 4,511).
The costs for the day hospital group appear to be higher, partly because half of the patients (n=35) received inpatient care on top of day care.
Synthesis of costs and benefits
The analysis demonstrated that day hospital care was more effective but more costly than inpatient care. An incremental cost-effectiveness analysis was conducted, and this demonstrated that day hospital care resulted in a total support cost of 12,267 per additional unit of BPRS score.
